Efficient systemic CNS delivery of a therapeutic antisense oligonucleotide with a blood-brain barrier-penetrating ApoE-derived peptide

Paper ID: PAPER000108
Year: 2024
DOI: 10.1016/j.biopha.2024.116737
PMID: 38749176
Journal: Biomedicine & Pharmacotherapy
Source URL

Experiments

EXP000526 with BPP1 (PMO (antisense oligonucleotide))
EXP000527 with BPP2 (PMO (antisense oligonucleotide))
EXP000528 with BPP3 (PMO (antisense oligonucleotide))
EXP000529 with BPP4 (PMO (antisense oligonucleotide))
EXP000530 with BPP5 (PMO (antisense oligonucleotide))
EXP000531 with BPP6 (PMO (antisense oligonucleotide))
EXP000532 with BPP7 (PMO (antisense oligonucleotide))
EXP000533 with BPP8 (PMO (antisense oligonucleotide))
EXP000534 with BPP8 (PMO)
EXP000535 with BPP9 (PMO (antisense oligonucleotide))
EXP000536 with BPP9 (PMO)
EXP000537 with BPP10 (PMO (antisense oligonucleotide))
EXP000538 with BPP11 (PMO (antisense oligonucleotide))
EXP000539 with BPP12 (PMO (antisense oligonucleotide))
EXP000540 with BPP12 (PMO)